AORT Stock Analysis: Buy, Sell, or Hold?
AORT - Artivion, Inc.
$25.06
-0.67 (-2.60%)
▼
5d:
+4.03%
30d:
+16.83%
90d:
-31.79%
BUY
MODERATE Confidence
Analysis Updated: Jul 17, 2026 12:00 AM ET
Earnings: Aug 06, 2026
17d
Get Alerted When AORT Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: AORT shows positive signals but monitor for confirmation. Market pricing in 2.5% decline. Moderate conviction.
💡 BUY OPPORTUNITY: AORT shows positive signals but monitor for confirmation. Market pricing in 2.5% decline. Moderate conviction.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$35.05
Based on 14.5% avg growth
INTRINSIC VALUE TODAY
$21.76
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 25.0x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: AORT is currently trading at $25.06, which is considered extended relative to its 30-day fair value range of $21.08 to $24.36. The stock's valuation (Forward PE: 34.8) is in line with its historical norms (37.6). Remarkably, the market is currently pricing in an annual earnings decline of 2.5% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, AORT is in a strong downtrend. Immediate support is located at $22.83, while resistance sits at $26.06.
Market Sentiment: AORT has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $42.00 (+67.6%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, AORT is in a strong downtrend. Immediate support is located at $22.83, while resistance sits at $26.06.
Market Sentiment: AORT has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $42.00 (+67.6%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$21.08 -
$24.36
Company Quality Score
61/100
(BUY)
Options IV Signal
46th percentile
(NORMAL)
Volume Confirmation
HIGH
Confidence Score
63.5%
All Signals
- BEARISH: Price extended above range
- NEUTRAL: Options fairly priced (IV 46th percentile)
- BULLISH: Strong technical setup (75/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 67.6% below Wall St target ($42.00)
Trading Range Analysis
30-Day Trading Range
$21.08 -
$24.36
Current vs Trading Range
EXTENDED
Expected Move (7 Days)
±$3.07
(12.3%)
Support & Resistance Levels
Support Level
$22.83
Resistance Level
$26.06
Current Trend
Strong Downtrend
Technical data as of
Jul 17, 2026
Fundamental Context
Forward P/E (Next Year Est.)
34.81
Wall Street Target
$42.00
(+67.6%)
Revenue Growth (YoY)
17.5%
Profit Margin
2.5%
Valuation Discount vs History
-2.5% cheaper
PE vs Historical
34.8 vs 37.6
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-2.5%
(market-implied from PE analysis)
1-Year Target
$24.43
(-3%)
2-Year Target
$23.82
(-5%)
3-Year Target
$23.23
(-7%)
3-Yr Target (if PE normalizes)
(PE: 35→38)
$25.09
(+0%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 34.8, Growth: 63.0%)
$84.58
(+238%)
Base:
(SPY PE: 21.0, Growth: 63.0%)
$51.05
(+104%)
Bear:
(PE: 17.9, Growth: 63.0%)
$43.40
(+73%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (152x PE), but valuation improves significantly next year (35x PE) as earnings recover.
Forward PE: 151.52 | Forward EPS (Implied): $0.17
Bull Case
$30.26
(+21%)
Analyst growth 15.0%, PE expands to 159.1
Base Case
$25.06
(0%)
Market implied 0.0%, PE stable at 151.5
Bear Case
$19.17
(-24%)
Severe decline -15.0%, PE contracts to 136.4
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 34.8 to 37.6
Stabilization Target:
$27.07
(+8.0%)
PE Expansion Potential:
+8.0%
Share & Embed Analysis
Last updated: July 19, 2026 3:24 AM ET
Data refreshes hourly during market hours. Next update: 4:24 AM
Data refreshes hourly during market hours. Next update: 4:24 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is AORT showing a specific setup today?
Insider Activity (6 Months)
0
Buys
20
Sells
Net
INSIDERS SELLING
Recent Transactions
Jean F Holloway
SELL
8962 shares
2026-03-04
Marshall S Stanton
SELL
2149 shares
2026-03-03
Lance A Berry
SELL
6316 shares
2026-03-03
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BSX
Boston Scientific Corp |
STRONG BUY
34 analysts |
$74 | 62 BUY |
|
DXCM
DexCom Inc |
STRONG BUY
27 analysts |
$85 | 63 BUY |
|
ABT
Abbott Laboratories |
STRONG BUY
27 analysts |
$116 | 67 BUY |
|
MDT
Medtronic PLC |
BUY
32 analysts |
$97 | 66 BUY |
|
EW
Edwards Lifesciences Corp |
HOLD
32 analysts |
$98 | 45 HOLD |
Advanced AORT Option Strategies
Professional options setups generated by AI based on today's AORT price and gamma walls.
